News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Israeli Biotech Macrocure Sets Terms for $75 Million IPO


7/31/2014 7:16:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Macrocure, a late-stage Israeli biotech developing white blood cell injections to treat hard-to-heal wounds, announced terms for its IPO on Friday. The Petach Tikva, Israel-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, it would command a fully diluted market value of $264 million.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at Nasdaq


comments powered by Disqus
Macrocure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES